Ranked #1,536 of 8,699 institutional investors
Tang Capital Management LLC
San Diego, CA
$1.92B
US stock portfolio at live prices · today −$28.5M (−1.46%)
Live prices, last trade 11:31 AM ET
- Value at quarter end (Q3 2026)
- $2.16B
- Change from Q2 2026
- −$27.7M (−1.27%)
- Positions
- 42 · 5 new, 1 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: $11.2M of convertible notes and other principal-amount securities. $186M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesAUPH 10.1%SYRE 9.38%TARS 7.43%LKFT 6.90%MIRM 6.30%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| AUPH Aurinia Pharmaceuticals Inc. | 13,044,106 | $193M | 10.1% | Unchanged |
| SYRE Spyre Therapeutics, Inc. | 1,892,200 | $180M | 9.38% | Unchanged |
| TARS Tarsus Pharmaceuticals, Inc. | 1,917,666 | $143M | 7.43% | Added +22% |
| LKFT Lakefront Biotherapeutics NV | 3,985,991 | $133M | 6.90% | Added +5% |
| MIRM Mirum Pharmaceuticals, Inc. | 1,236,027 | $121M | 6.30% | Unchanged |
| CORT Corcept Therapeutics Incorporated | 1,500,000 | $95.2M | 4.95% | Unchanged |
| PTCT PTC Therapeutics, Inc. | 1,500,000 | $86.7M | 4.51% | Unchanged |
| CELC Celcuity Inc. | 1,464,594 | $80.0M | 4.16% | Added +11% |
| IMCR Immunocore Holdings plc | 2,884,149 | $76.9M | 4.00% | Added +9% |
| ANAB AnaptysBio, Inc. | 1,474,262 | $69.0M | 3.59% | Added +11% |
| SPY State Street SPDR S&P 500 ETF Trust | 95,000 | $67.0M | 3.49% | Reduced −23% |
| VRDN Viridian Therapeutics, Inc. | 1,792,626 | $55.2M | 2.87% | Unchanged |
| ANIP ANI Pharmaceuticals, Inc. | 707,500 | $48.5M | 2.52% | Unchanged |
| CMPS COMPASS Pathways plc | 5,200,000 | $42.2M | 2.20% | Added +4% |
| BNTX BioNTech SE | 470,000 | $38.1M | 1.98% | Unchanged |
| NVCT Nuvectis Pharma, Inc. | 1,577,968 | $30.4M | 1.58% | Added +2% |
| PGEN Precigen, Inc. | 6,417,500 | $27.3M | 1.42% | Unchanged |
| ARDX Ardelyx, Inc. | 9,047,134 | $27.1M | 1.41% | New |
| FULC Fulcrum Therapeutics, Inc. | 7,080,945 | $26.2M | 1.36% | Added +9% |
| NNDM Nano Dimension Ltd. | 20,926,847 | $22.6M | 1.18% | Added +46% |
| DNTH Dianthus Therapeutics, Inc. | 264,692 | $22.3M | 1.16% | Unchanged |
| AVIR Atea Pharmaceuticals, Inc. | 4,814,700 | $18.7M | 0.97% | Unchanged |
| INSM Insmed Incorporated | 100,000 | $14.5M | 0.75% | Unchanged |
| VERA Vera Therapeutics, Inc. | 500,000 | $12.9M | 0.67% | New |
| VKTX Viking Therapeutics, Inc. | 500,000 | $12.7M | 0.66% | Unchanged |
| NUVB Nuvation Bio Inc. | 3,299,557 | $12.6M | 0.66% | Unchanged |
| CMPX Compass Therapeutics, Inc. | 17,990,782 | $12.1M | 0.63% | Unchanged |
| IDYA IDEAYA Biosciences, Inc. | 450,000 | $11.7M | 0.61% | Unchanged |
| LEGN Legend Biotech Corporation | 700,000 | $11.1M | 0.58% | New |
| MRNA Moderna, Inc. | 50,000 | $10.0M | 0.52% | Unchanged |
| STOK Stoke Therapeutics, Inc. | 300,000 | $8.2M | 0.43% | Unchanged |
| BOLD Boundless Bio, Inc. | 2,840,635 | $6.6M | 0.34% | Added +11% |
| DERM Journey Medical Corporation | 1,610,000 | $5.3M | 0.28% | Unchanged |
| PMVP PMV Pharmaceuticals, Inc. | 7,285,085 | $5.2M | 0.27% | Added +72% |
| PLRX Pliant Therapeutics, Inc. | 6,141,261 | $3.7M | 0.19% | Unchanged |
| HRTX Heron Therapeutics, Inc. | 8,971,427 | $2.4M | 0.12% | Added +44% |
| WVE Wave Life Sciences, Inc. | 600,000 | $1.6M | <0.1% | Unchanged |
| LENZ LENZ Therapeutics, Inc. | 451,114 | $1.4M | <0.1% | Unchanged |
| ALT Altimmune, Inc. | 666,022 | $912K | <0.1% | Unchanged |
| SION Sionna Therapeutics, Inc. | 125,000 | $361K | <0.1% | New |
| RCKT Rocket Pharmaceuticals, Inc. | 100,000 | $204K | <0.1% | Unchanged |
| SKYE Skye Bioscience, Inc. | 200,000 | $134K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| CAPR Capricor Therapeutics, Inc. | 4,099,900 | $32.3M |